Pope Francis, who had part of his lung removed as a young man, recently spent several weeks hospital due to a respiratory ...

A new phase 3 trial shows that DPP-1 inhibition with brensocatib reduces exacerbations and slows lung function decline in ...

Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM ...

For patients with bronchiectasis, brensocatib leads to a lower annualized rate of pulmonary exacerbations, according to a ...

The dipeptidyl peptidase 1 (DPP-1) inhibitor cut the annualized rate of pulmonary exacerbations by around 20% compared with ...

Incorporated announced that positive results from the pivotal phase 3 ASPEN study of brensocatib in patients with non-cystic ...

President Trump ordered flags across the United States to be flown at half-staff until sunset on the day of the pope's ...

The declaration of death said the pope had Type 2 diabetes and high blood pressure, along with bronchiectasis, a chronic lung condition.

The following is a summary of "Bronchiectasis In Patients With Inflammatory Bowel Diseases – Prevalence, Predictors, And ...

Surgery is essential for the effective management of bronchiectasis. Segmentectomy, while a challenging procedure, has become more attainable due to advancements in thin-slice CT scans and ...

The article titled "Effects of the DPP-1 Inhibitor HSK31858 in Adults with Bronchiectasis in China (SAVE-BE): A Phase 2, Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial," focuses ...